Storage diseases: New insights into sphingolipid functions

Trends in Cell Biology

Volumn 13, Issue 4, 2003, Pages 195-203

  Sillence, Dan J ^a   Platt, Frances M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN;

CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CELL SURFACE; CLINICAL FEATURE; CYTOSOL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FABRY DISEASE; GAUCHER DISEASE; GM1 GANGLIOSIDOSIS; HUMAN; HURLER SYNDROME; LIPID COMPOSITION; LIPID STORAGE; LIPIDOSIS; LYSOSOME STORAGE DISEASE; MACROPHAGE ACTIVATION; MANNOSIDOSIS; MAROTEAUX LAMY SYNDROME; MEMBRANE STRUCTURE; MUCOPOLYSACCHARIDOSIS 7; NIEMANN PICK DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SANDHOFF DISEASE; SANFILIPPO SYNDROME; TAY SACHS DISEASE;

EUKARYOTA;

EID: 0037376341     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(03)00033-3     Document Type: Review

References (93)

1. Holthuis J.C., et al. The organizing potential of sphingolipids in intracellular membrane transport. Physiol. Rev. 81:2001;1689-1723.
2. Reiss-Husson F. Structure of liquid-crystalline phases of different phospholipids, monoglycerides, sphingolipids in the absence or presence of water. J. Mol. Biol. 25:1967;363-382.
3. Meikle P.J., et al. Prevalence of lysosomal storage disorders. J. Am. Med. Assoc. 281:1999;249-254.
4. Beutler E., Grabowski G. Gaucher disease. Scriver C.R., et al. The Metabolic and Molecular Basis of Inherited Diseases. 2001;3636-3668 McGraw-Hill.
5. Wada R., et al. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10954-10959.
6. Jeyakumar, M. et al. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain (in press).
7. Suzuki K. Twenty five years of the 'psychosine hypothesis': a personal perspective of its history and present status. Neurochem. Res. 23:1998;251-259.
8. Puri V., et al. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J. Cell Biol. 154:2001;535-548.
9. Puri V., et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1:1999;386-388.
10. Venkataraman K., et al. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine [C18-(Dihydro)ceramide] synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 277:2002;35642-35649.
11. 6-fold increased cell sensitivity to verocytotoxin. role of P-glycoprotein in glycolipid synthesis. J. Biol. Chem. 275:2000;6246-6251.
12. Simons K., van Meer G. Lipid sorting in epithelial cells. Biochemistry. 27:1988;6197-6202.
13. Koval M., Pagano R.E. Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and Niemann-Pick, type A fibroblasts. J. Cell Biol. 111:1990;429-442.
14. Koval M., Pagano R.E. Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts. J. Cell Biol. 108:1989;2169-2181.
15. Hoekstra D., Kok J.W. Trafficking of glycosphingolipids in eukaryotic cells; sorting and recycling of lipids. Biochim. Biophys. Acta. 1113:1992;277-294.
16. Pagano R.E., Chen C.S. Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Ann. New York Acad. Sci. 845:1998;152-160.
17. Zacharias D.A., et al. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 296:2002;913-916.
18. Van Meer G. The different hues of lipid rafts. Science. 296:2002;855-857.
19. Schutz G.J., et al. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J. 19:2000;892-901.
20. Chen C.S., et al. Changes in the spectral properties of a plasma membrane lipid analog during the first seconds of endocytosis in living cells. Biophys. J. 72:1997;37-50.
21. Wang T.Y., Silvius J.R. Different sphingolipids show differential partitioning into sphingolipid/cholesterol-rich domains in lipid bilayers. Biophys. J. 79:2000;1478-1489.
22. Sandvig K., et al. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108:1989;1331-1343.
23. Schapiro F.B., et al. pH-independent retrograde targeting of glycolipids to the Golgi complex. Am. J. Physiol. 274:1998;C319-C332.
24. Vyas K.A., et al. Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol. Chem. 382:2001;241-250.
25. Gomez-Mouton C., et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9642-9647.
26. Mukherjee S., et al. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J. Cell Biol. 144:1999;1271-1284.
27. Chen C.S., et al. Broad screening test for sphingolipid-storage diseases. Lancet. 354:1999;901-905.
28. Sillence D.J., et al. Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res. 43:2002;1837-1845.
29. Futerman A.H., Pagano R.E. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem. J. 280:1991;295-302.
30. Jeckel D., et al. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J. Cell Biol. 117:1992;259-267.
31. Burger K.N.J., et al. Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis. J. Cell Biol. 133:1996;15-28.
32. Sprong H., et al. Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J. Cell Biol. 155:2001;369-380.
33. Yamashita T., et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9142-9147.
34. Vyas A.A., et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8412-8417.
35. White J., et al. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol. 147:1999;743-760.
36. Gagescu R., et al. The recycling endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft components. Mol. Biol. Cell. 11:2000;2775-2791.
37. Gruenberg J. The endocytic pathway: a mosaic of domains. Nat. Rev. Mol. Cell Biol. 2:2001;721-730.
38. Sillence D.J. Apoptosis and signalling in acid sphingomyelinase deficient cells. BMC Cell Biol. 2:2001;24.
39. Nichols B.J., et al. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153:2001;529-541.
40. Nichols B.J. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4:2002;374-378.
41. Sabharanjak S., et al. GPI-anchored proteins are delivered to recycling endosomes via a distinct Cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell. 2:2002;411-423.
42. Kobayashi T., et al. The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol. Biol. Cell. 11:2000;1829-1843.
43. Sandvig K., van Deurs B. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18:2002;1-24.
44. Lencer W.I., et al. Membrane traffic and the cellular uptake of cholera toxin. Biochim. Biophys. Acta. 1450:1999;177-190.
45. Pacuszka T., et al. Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. Biochemistry. 30:1991;2563-2570.
46. Badizadegan K., et al. Heterogeneity of detergent-insoluble membranes from human intestine containing caveolin-1 and ganglioside GM1. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G895-G904.
47. Rodighiero C., et al. A cholera toxin B-subunit variant that binds ganglioside GM1 but fails to induce toxicity. J. Biol. Chem. 276:2001;36939-36945.
48. Wolf A.A., et al. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J. Cell Biol. 141:1998;917-927.
49. Falguieres T., et al. Targeting of shiga toxin b-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell. 12:2001;2453-2468.
50. Badizadegan K., et al. Floating cholera toxin into epithelial cells: functional association with caveolae-like detergent-insoluble membrane microdomains. Int. J. Med. Microbiol. 290:2000;403-408.
51. Arab S., Lingwood C.A. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J. Cell. Physiol. 177:1998;646-660.
52. Munro S. An investigation of the role of transmembrane domains in Golgi protein retention. EMBO J. 14:1995;4695-4704.
53. Diamond J.M. Human genetics. Jewish lysosomes. Nature. 368:1994;291-292.
54. George T., et al. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77. Cell Mol. Biol. 47:2001;1179-1185.
55. Khine A.A., et al. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J. Cell. Physiol. 176:1998;281-292.
56. Lin S.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3:2001;802-808.
57. Xie X., et al. Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J. Neurochem. 81:2002;1185-1195.
58. Bodennec J., et al. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide. FASEB J. 16:2002;1814-1816.
59. Miljan E.A., et al. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277:2002;10108-10113.
60. Rusnati M., et al. Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4367-4372.
61. Mutoh T., et al. Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem. Res. 27:2002;801-806.
62. de Duve C. Microbodies in the living cell. Sci. Am. 248:1983;74-84.
63. Gillard B.K., et al. Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology. 8:1998;885-890.
64. Gahl W. Lysosomal transport disorders: cystinosis and sialic acid storage disorders. Scriver C., et al. The Metabolic and Molecular Bases of Inherited Disease. 1995;3763-3797 McGraw-Hill.
65. Zervas M., et al. Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr. Biol. 11:2001;1283-1287.
66. Zhang M., et al. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 277:2002;33300-33310.
67. Sprong H., et al. How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell Biol. 2:2001;504-513.
68. Liu Y., et al. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Hum. Mol. Genet. 9:2000;1087-1092.
69. van Helvoort A., et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
70. Chambenoit O., et al. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276:2001;9955-9960.
71. Davies J.P., et al. Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science. 290:2000;2295-2298.
72. Naureckiene S., et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 290:2000;2298-2301.
73. Bargal R., et al. Identification of the gene causing mucolipidosis type IV. Nat. Genet. 26:2000;118-123.
74. LaPlante J.M., et al. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 532:2002;183-187.
75. Fares H., Greenwald I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat. Genet. 28:2001;64-68.
76. Bach G., et al. Elevated lysosomal pH in mucolipidosis type IV cells. Clin. Chim. Acta. 280:1999;173-179.
77. Kobayashi T., et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell Biol. 1:1999;113-118.
78. Neufeld E.B., et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274:1999;9627-9635.
79. Choudhury A., et al. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109:2002;1541-1550.
80. Holtta-Vuori M., et al. Mobilization of late-endosomal cholesterol is inhibited by Rab guanine nucleotide dissociation inhibitor. Curr. Biol. 10:2000;95-98.
81. Lebrand C., et al. Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J. 21:2002;1289-1300.
82. Goldin E., et al. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Biochim. Biophys. Acta. 1127:1992;303-311.
83. Rodriguez-Lafrasse C., et al. Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders. Biochim. Biophys. Acta. 1226:1994;138-144.
84. Cox T., et al. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet. 355:2000;1481-1485.
85. Lachmann R.H., Platt F.M. Substrate reduction therapy for glycosphingolipid storage disorders. Expert Opin. Invest. Drugs. 10:2001;455-466.
86. Scriver C.R., et al. Lysosomal disorders. Scriver C.R., et al. The Metabolic and Molecular Basis of Inherited Diseases. 2001;3371-3877 McGraw Hill.
87. Goldin E., et al. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Biochim. Biophys. Acta. 1127:1992;303-311.
88. Butler J.D., et al. Niemann-Pick C disease: cystine and lipids accumulate in the murine model of this lysosomal cholesterol lipidosis. Biochem. Biophys. Res. Commun. 196:1993;154-159.
89. Zhang M., et al. Sterol-modulated glycolipid sorting occurs in Niemann-Pick C1 late endosomes. J. Biol. Chem. 276:2001;3417-3425.
90. Zervas M., et al. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol. 60:2001;49-64.
91. Lusa S., et al. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J. Cell Sci. 114:2001;1893-1900.
92. Yano T., et al. Accumulation of GM2 ganglioside in Niemann-Pick disease type C fibroblasts. Proc. Jpn. Acad. 72:1996;214-219.
93. Sugimoto Y., et al. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12391-12396.